Correction to: Synthesis of 99mTc-DOTMP and Its Preclinical Evaluation as a Multidentate Imaging Agent for Skeletal Metastases, by Datta A., et al. Cancer Biotherapy and Radiopharmaceuticals 2009;24(1):123-128. DOI: 10.1089/cbr.2008.0536.

Author unknown

Open source

DOI
10.1089/cbr.2008.0536.correx
Published
2022 Mar
Container
Cancer biotherapy & radiopharmaceuticals
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1089/cbr.2008.0536.correx,
  title = {Correction to: Synthesis of 99mTc-DOTMP and Its Preclinical Evaluation as a Multidentate Imaging Agent for Skeletal Metastases, by Datta A., et al. Cancer Biotherapy and Radiopharmaceuticals 2009;24(1):123-128. DOI: 10.1089/cbr.2008.0536.},
  year = {2022},
  journal = {Cancer biotherapy \& radiopharmaceuticals},
  doi = {10.1089/cbr.2008.0536.correx},
  url = {https://doi.org/10.1089/cbr.2008.0536.correx}
}

RIS

TY  - JOUR
TI  - Correction to: Synthesis of 99mTc-DOTMP and Its Preclinical Evaluation as a Multidentate Imaging Agent for Skeletal Metastases, by Datta A., et al. Cancer Biotherapy and Radiopharmaceuticals 2009;24(1):123-128. DOI: 10.1089/cbr.2008.0536.
PY  - 2022
JO  - Cancer biotherapy & radiopharmaceuticals
DO  - 10.1089/cbr.2008.0536.correx
UR  - https://doi.org/10.1089/cbr.2008.0536.correx
ER  - 

APA

Correction to: Synthesis of 99mTc-DOTMP and Its Preclinical Evaluation as a Multidentate Imaging Agent for Skeletal Metastases, by Datta A., et al. Cancer Biotherapy and Radiopharmaceuticals 2009;24(1):123-128. DOI: 10.1089/cbr.2008.0536.. (2022). Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1089/cbr.2008.0536.correx

Source records